Jessie Neuckermans

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Mesenchymal Stem Cells

Structural Basis

Newly Diagnosed

Gold Nanoparticles

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Jessie Neuckermans, Sien Lequeue, Paul Claes, Anja Heymans, Juliette H Hughes, Haaike Colemonts-Vroninks, Lionel Marcélis, Georges Casimir, Philippe Goyens, Geert A Martens, James A Gallagher, Tamara Vanhaecke, George Bou-Gharios, Joery De Kock
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. Genes 14 (3) (2023)
Jessie Neuckermans, Sien Lequeue, Paul Claes, Anja Heymans, Juliette H Hughes, Haaike Colemonts-Vroninks, Lionel Marcélis, Georges Casimir, Philippe Goyens, Geert A Martens, James A Gallagher, Tamara Vanhaecke, George Bou-Gharios, Joery De Kock
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. Genes 14 (3) (2023)
Jessie Neuckermans, Sien Lequeue, Paul Claes, Anja Heymans, Juliette H Hughes, Haaike Colemonts-Vroninks, Lionel Marcélis, Georges Casimir, Philippe Goyens, Geert A Martens, James A Gallagher, Tamara Vanhaecke, George Bou-Gharios, Joery De Kock
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype. Genes 14 (3) (2023)
Jessie Neuckermans, Alan Mertens, Dinja De Win, Ulrich Schwaneberg, Joery De Kock
A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors. Scientific reports 9 (1) (2019)